Experimental, systems, and computational approaches to understanding the MicroRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients

Circulation Research

Volumn 120, Issue 4, 2017, Pages 701-712

  Agarwal, Udit ^a,b   George, Alex ^a   Bhutani, Srishti ^a   Ghosh Choudhary, Shohini ^a   Maxwell, Joshua T ^a,b   Brown, Milton E ^a   Mehta, Yash ^a   Platt, Manu O ^a   Liang, Yaxuan ^c   Sahoo, Susmita ^c   Davis, Michael E ^a,b  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac progenitor cells; exosome; microRNA; modeling; systems biology

Indexed keywords

MICRORNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CLINICAL EVALUATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DRESSLER SYNDROME; EXOSOME; HEART ATRIUM APPENDAGE; HEART FUNCTION; HEART PROTECTION; HEART SURGERY; HUMAN; HUMAN CELL; NEWBORN HYPOXIA; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGE; ANIMAL; CELL CULTURE; CELL HYPOXIA; CHILD; COMPREHENSION; DOUBLE BLIND PROCEDURE; INFANT; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; RANDOMIZATION; STEM CELL; TRANSPLANTATION;

AGE FACTORS; ANIMALS; CELL HYPOXIA; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COMPREHENSION; DOUBLE-BLIND METHOD; EXOSOMES; HUMANS; INFANT; INFANT, NEWBORN; MICRORNAS; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS; RATS, NUDE; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 85000631212     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309935     Document Type: Article

References (37)

1. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80
2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P, Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003 114 763 776
3. Maxeiner H, Krehbiehl N, Müller A, Woitasky N, Akintürk H, Müller M, Weigand MA, Abdallah Y, Kasseckert S, Schreckenberg R, Schlüter KD, Wenzel S, New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail 2010 12 730 737. doi: 10.1093/eurjhf/hfq063
4. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012 126 S54 S64. doi: 10.1161/CIRCULATIONAHA.112.092627
5. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012 379 895 904. doi: 10.1016/S0140-6736(12)60195-0
6. Ishigami S, Ohtsuki S, Tarui S, Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res 2015 116 653 664. doi: 10.1161/CIRCRESAHA.116.304671
7. Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, Oh H, Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg 2015 150 1198 1207, 1208.e1. doi: 10.1016/j.jtcvs.2015.06.076
8. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007 9 654 659. doi: 10.1038/ncb1596
9. Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD, Davis ME, Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 2015 116 255 263. doi: 10.1161/CIRCRESAHA.116.304360
10. Tseliou E, Fouad J, Reich H, Slipczuk L, de Couto G, Aminzadeh M, Middleton R, Valle J, Weixin L, Marbán E, Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles. J Am Coll Cardiol 2015 66 599 611. doi: 10.1016/j.jacc.2015.05.068
11. Khan M, Nickoloff E, Abramova T, Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res 2015 117 52 64. doi: 10.1161/CIRCRESAHA.117.305990
12. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW, Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 2011 109 724 728. doi: 10.1161/CIRCRESAHA.111.253286
13. Ibrahim AG, Cheng K, Marbán E, Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2014 2 606 619. doi: 10.1016/j.stemcr.2014.04.006
14. Simon MC, Keith B, The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 2008 9 285 296. doi: 10.1038/nrm2354
15. Agarwal U, Smith AW, French KM, Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure. Stem Cells Transl Med 2016 5 883 892. doi: 10.5966/sctm.2015-0241
16. He M, Crow J, Roth M, Zeng Y, Godwin AK, Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip 2014 14 3773 3780. doi: 10.1039/c4lc00662c.
17. Lane RE, Korbie D, Anderson W, Vaidyanathan R, Trau M, Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci Rep 2015 5 7639. doi: 10.1038/srep07639
18. Kervadec A, Bellamy V, El Harane N, Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant 2016 35 795 807. doi: 10.1016/j.healun.2016.01.013
19. Sahoo S, Losordo DW, Exosomes and cardiac repair after myocardial infarction. Circ Res 2014 114 333 344. doi: 10.1161/CIRCRESAHA.114.300639
20. Emanueli C, Shearn AI, Angelini GD, Sahoo S, Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul Pharmacol 2015 71 24 30. doi: 10.1016/j.vph.2015.02.008
21. Singla DK, Stem cells and exosomes in cardiac repair. Curr Opin Pharmacol 2016 27 19 23. doi: 10.1016/j.coph.2016.01.003
22. Lai RC, Chen TS, Lim SK, Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011 6 481 492. doi: 10.2217/rme.11.35
23. Zhang Z, Yang J, Yan W, Li Y, Shen Z, Asahara T, Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J Am Heart Assoc 2016 5 pii: e002856. doi: 10.1161/JAHA.115.002856
24. Malik ZA, Kott KS, Poe AJ, Kuo T, Chen L, Ferrara KW, Knowlton AA, Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 2013 304 H954 H965. doi: 10.1152/ajpheart.00835.2012
25. Gupta S, Knowlton AA, HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007 292 H3052 H3056. doi: 10.1152/ajpheart.01355.2006
26. Marques FZ, Vizi D, Khammy O, Mariani JA, Kaye DM, The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail 2016 18 1000 1008. doi: 10.1002/ejhf.517
27. Lew WY, Bayna E, Dalle Molle E, Contu R, Condorelli G, Tang T, Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice. PLoS One 2014 9 e107556. doi: 10.1371/journal.pone.0107556
28. Derda AA, Thum S, Lorenzen JM, Bavendiek U, Heineke J, Keyser B, Stuhrmann M, Givens RC, Kennel PJ, Schulze PC, Widder JD, Bauersachs J, Thum T, Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. Int J Cardiol 2015 196 115 122. doi: 10.1016/j.ijcard.2015.05.185
29. Xia Y, Sheng J, Liang GY, Liu DX, Tang Q, Cheng AP, miR-96 inhibits cardiac hypertrophy by targeting growth factor receptor-bound 2. Genet Mol Res 2015 14 18958 18964. doi: 10.4238/2015.December.29.2
30. Sun X, Zhang C, MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR. Int J Clin Exp Pathol 2015 8 14500 14506
31. Li N, Hwangbo C, Jaba IM, Zhang J, Papangeli I, Han J, Mikush N, Larrivée B, Eichmann A, Chun HJ, Young LH, Tirziu D, miR-182 modulates myocardial hypertrophic response induced by angiogenesis in heart. Sci Rep 2016 6 21228. doi: 10.1038/srep21228
32. Meng Z, Wang Y, Lin Y, Nan S, Xu W, Hu B, Shen E, [MicroRNA-182 modulates high glucose-induced cardiomyocyte hypertrophy via targeting Rac1]. Zhonghua Xin Xue Guan Bing Za Zhi 2015 43 619 624
33. Kim JO, Song DW, Kwon EJ, Hong SE, Song HK, Min CK, Kim DH, miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways. PLoS One 2015 10 e0122509. doi: 10.1371/journal.pone.0122509
34. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S, Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc Natl Acad Sci U S A 2011 108 8287 8292. doi: 10.1073/pnas.1105254108
35. Xiong H, Luo T, He W, Xi D, Lu H, Li M, Liu J, Guo Z, Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression. Exp Biol Med (Maywood) 2016 241 25 30. doi: 10.1177/1535370215591831
36. He S, Liu P, Jian Z, Li J, Zhu Y, Feng Z, Xiao Y, miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun 2013 441 763 769. doi: 10.1016/j.bbrc.2013.10.151
37. Pan L, Huang BJ, Ma XE, Wang SY, Feng J, Lv F, Liu Y, Liu Y, Li CM, Liang DD, Li J, Xu L, Chen YH, MiR-25 protects cardiomyocytes against oxidative damage by targeting the mitochondrial calcium uniporter. Int J Mol Sci 2015 16 5420 5433. doi: 10.3390/ijms16035420